Onelar (Duloxetine)

Duloxetine, the active ingredient in Onelar, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as a unknown/unknown for oral use. It treats major depressive disorder and generalized anxiety disorder in adults. GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Duloxetine is an SNRI that modulates neurotransmitter activity in mood‑related pathways.

- Major Depressive Disorder: Improves depressive symptoms and functional outcomes. - Generalized Anxiety Disorder: Reduces anxiety symptoms and associated distress. - Diabetic Peripheral Neuropathy Pain: Alleviates chronic neuropathic pain in the lower limbs. - Fibromyalgia: Decreases widespread pain and improves sleep quality. - Chronic Musculoskeletal Musculoskeletal  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​

Duloxetine may exhibit         …    …  ...  …  …  … … …  …  … …  …   … ....